Keratin expression profiling of transitional epithelium in the painful bladder syndrome/interstitial cystitis

American Journal of Clinical Pathology

Volumn 125, Issue 1, 2006, Pages 105-110

  Laguna, Pilar ^a   Smedts, Frank ^b   Nordling, Jörgen ^c   Horn, Thomas ^c   Bouchelouche, Kirsten ^c   Hopman, Anton ^d   De La Rosette, Jean ^a  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b Foundation of Collaborating Hospitals of Eastern Groningen   (Netherlands)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Bladder; Cytokeratins; Intermediate filaments; Pelvic pain syndrome

Indexed keywords

ANTIBODY; CYTOKERATIN 13; CYTOKERATIN 14; CYTOKERATIN 17; CYTOKERATIN 18; CYTOKERATIN 20; CYTOKERATIN 5; CYTOKERATIN 7; CYTOKERATIN 8; KERATIN;

ADULT; ARTICLE; BLADDER BIOPSY; CELL COMPARTMENTALIZATION; CELL DIFFERENTIATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTALGIA; DISEASE SEVERITY; FEMALE; GENE EXPRESSION PROFILING; HUMAN; HUMAN TISSUE; INTERSTITIAL CYSTITIS; MORPHOLOGY; PHENOTYPE; PRIORITY JOURNAL; SQUAMOUS EPITHELIUM; SYMPTOMATOLOGY; UROTHELIUM;

EID: 30644461489     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/W342BWMDMDDBCTVH     Document Type: Article

References (25)

1. Sant GR. Interstitial cystitis. Curr Opin Obstet Gynecol. 1997;9:332-336.
2. Hurst RE, Roy JB, Min KW, et al. A deficit of chondroitin sulfate proteoglycans on the bladder uroepithelium in interstitial cystitis. Urology. 1996;48:817-821.
3. Elbadawi A. Interstitial cystitis: a critique of current concepts with a new proposal for pathology diagnosis and pathogenesis. Urology. 1997;49(suppl 5a):14-40.
4. Elbadawi AE, Light JK. Distinctive ultrastructural pathology of nonulcerative interstitial cystitis: new observations and their potential significance in pathogenesis. Urol Int. 1996;56:137-162.
5. Hofmeister MA, Fang HE, Ratliff TL, et al. Mast cells and nerve fibers in interstitial cystitis (IC): an algorithm for histology diagnosis via quantitative image analysis and morphometry QIAM. Urology. 1997;49(suppl 5a):52-57.
6. Moll R, Franke WW, Schiller DL, et al. The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells. Cell. 1982;31:ll-24.
7. Ramaekers FCS, Smedts F, Vooijs GP. Keratins as differentiation markers in tumor biology and surgical pathology. In: Spandidos DA, ed. Current Perspectives in Molecular and Cellular Oncology: Mechanisms of Gene Regulation, Part A. London, England: JAI Press; 1992:285-318.
8. Schaafsma HE, Ramaekers FCS, van Muijen GNP, et al. Distribution of cytokeratin polypeptides in epithelia of the adult human urinary tract. Histochemistry. 1989;91:151-159.
9. Moll R, Achtstätter T, Becht E, et al. Cytokeratins in normal and malignant transitional epithelium: maintenance of expression of urothelial differentiation features in transitional cell carcinomas and bladder carcinoma culture lines. Am J Pathol. 1988;132:12344.
10. Smedts F, Ramaekers F, Robben H, et al. Changing patterns of keratin expression during progression of cervical intraepithelial neoplasia. Am J Pathol. 1990;136:657-668.
11. Moll R, Löwe A, Laufer J, et al. Cytokeratin 20 in human carcinomas: a new histodiagnostic marker detected by monoclonal antibodies. Am J Pathol. 1992;140:427-447.
12. Fall M, Johansson SL, Alderboug F. Chronic interstitial cystitis: a heterogeneous syndrome. J Urol. 1987;137:35-38.
13. Keay S, Warren JW. A hypothesis for the etiology of interstitial cystitis based on inhibited bladder repair. Med Hypotheses. 1998;51:79-83.
14. Ruggieri MR, Chelsky MJ, Resen SI, et al. Current findings and future research avenues in the study of interstitial cystitis. Urol Clin North Am. 1994;21:163-176.
15. Ratliff TL, Kluthe CG, McDougall EM. The etiology of interstitial cystitis. Urol Clin North Am. 1994;21:21-29.
16. Gillenwater JY, Wein AJ. Summary of the National Institute of Arthritis, Diabetes Digestive and Kidney Diseases Workshop on Interstitial Cystitis, National Institutes of Health, Bethesda, Maryland, August 28-29, 1987. J Urol. 1988;140:203-206.
17. Helpap B, Köllermann J. Assessment of basal cell status and proliferative patterns in flat and papillary urothelial lesions: a contribution to the new WHO classification of urothelial tumors of the urinary bladder. Hum Pathol. 2000;31:745-750.
18. Reis-Filho JS, Simpson PT, Martins A, et al. Distribution of p63 cytokeratins 5/6 and cytokeratin 14 in 51 normal and 400 neoplastic human tissue samples using TARI multi-tumor tissue microarray. Virchows Arch. 2003;443:122-132.
19. Vaidyanathan S, McDicken IW, Son BM, et al. Detection of early squamous metaplasia in bladder biopsies of spinal cord injury patients by immunostaining for cytokeratin 14. Spinal Cord. 2003;41:432-434.
20. Troyanovsky SM, Geulstein VI, Tchlpysheva TA, et al. Patterns of expression of keratin 17 in human epithelia: dependency on cell position. J Cell Sci. 1989;93:419-426.
21. Vaidyanathan S, McDicken IW, Ikin AJ, et al. A study of cytokeratin 20 immunostaining in urothelium of neuropathic bladder of patients with spinal cord injury. BMC Urol. 2002;2:7.
22. Romih P, Vennic P, Jezernik K. Appraisal of differentiation markers in urothelial cells. Appl Immunohistochem Mol Morphol. 2002;10:339-343.
23. Owen DW, Lane EB. The quest for the function of simple epithelial keratins. Bioessays. 2003;25:748-758.
24. Veranic P, Jezernik K. Trajectorial organisation of cytokeratins within the subapical region of umbrella cells. Cell Motil Cytoskeleton. 2002;53:317-325.
25. de la Rosette JJCLM, Smedts F, Schoots C, et al. Changing patterns of keratin expression could be associated with functional maturation of the developing human bladder. J Urol. 2002;168:709-713.